Will a fee-for-service payment for a young people's health assessment in general practice increase the detection of health risk behaviours and health conditions? Protocol for a cluster randomised controlled trial (RAd Health Trial)
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
INTRODUCTION: Adolescence is a period of major transition in physical, cognitive, social and emotional development, and the peak time for the onset of mental health conditions, substance use disorders and sexual and reproductive health risks. Prevention and treatment during this time can improve health and well-being now and into the future. However, despite clinical guidelines recommending annual preventive health assessments for young people, health professionals cite lack of consultation time and adequate funding as key barriers. This trial aims to determine whether a specific fee-for-service ('rebate payment') for a young person's health assessment, is effective and cost-effective at increasing the detection and management of health risk behaviours and conditions among young people.
METHODS AND ANALYSIS: This cluster randomised controlled trial will be conducted in Australian general practice. 42 general practices (clusters) will be randomly allocated 1:1 to either an intervention arm where general practitioners receive a rebate payment for each annual health assessment undertaken for 14-24-year-olds during a 2 year study period, or a control arm (no rebate). The rebate amount will be based on the Medical Benefits Schedule (Australia's list of health professional services subsidised by the Australian Government) currently available for similar age-based assessments. Our primary outcome will be the annual rate of risk behaviours and health conditions recorded in the patient electronic health record (eg, alcohol/drug use, sexual activity and mental health issues). Secondary outcomes include the annual rate of patient management activities related to health risks and conditions identified (eg, contraception prescribed, sexually transmitted infection tests ordered). A process evaluation will assess acceptability, adoption, fidelity and sustainability of the rebate; an economic evaluation will assess its cost-effectiveness. Analyses will be intention-to-treat.
ETHICS AND DISSEMINATION: Ethics approval has been obtained from University of Melbourne Human and Research Ethics Committee (2022-23435-29990-3). Findings will be published in peer-reviewed journals.
TRIAL REGISTRATION NUMBER: ACTRN12622000114741.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
BMJ open - 13(2023), 8 vom: 16. Aug., Seite e074154 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hocking, Jane S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adolescent |
|---|
| Anmerkungen: |
Date Completed 18.08.2023 Date Revised 20.08.2023 published: Electronic ANZCTR: ACTRN12622000114741 Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjopen-2023-074154 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36086063X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36086063X | ||
| 003 | DE-627 | ||
| 005 | 20231226210754.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjopen-2023-074154 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM36086063X | ||
| 035 | |a (NLM)37586870 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hocking, Jane S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Will a fee-for-service payment for a young people's health assessment in general practice increase the detection of health risk behaviours and health conditions? Protocol for a cluster randomised controlled trial (RAd Health Trial) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.08.2023 | ||
| 500 | |a Date Revised 20.08.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ANZCTR: ACTRN12622000114741 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a INTRODUCTION: Adolescence is a period of major transition in physical, cognitive, social and emotional development, and the peak time for the onset of mental health conditions, substance use disorders and sexual and reproductive health risks. Prevention and treatment during this time can improve health and well-being now and into the future. However, despite clinical guidelines recommending annual preventive health assessments for young people, health professionals cite lack of consultation time and adequate funding as key barriers. This trial aims to determine whether a specific fee-for-service ('rebate payment') for a young person's health assessment, is effective and cost-effective at increasing the detection and management of health risk behaviours and conditions among young people | ||
| 520 | |a METHODS AND ANALYSIS: This cluster randomised controlled trial will be conducted in Australian general practice. 42 general practices (clusters) will be randomly allocated 1:1 to either an intervention arm where general practitioners receive a rebate payment for each annual health assessment undertaken for 14-24-year-olds during a 2 year study period, or a control arm (no rebate). The rebate amount will be based on the Medical Benefits Schedule (Australia's list of health professional services subsidised by the Australian Government) currently available for similar age-based assessments. Our primary outcome will be the annual rate of risk behaviours and health conditions recorded in the patient electronic health record (eg, alcohol/drug use, sexual activity and mental health issues). Secondary outcomes include the annual rate of patient management activities related to health risks and conditions identified (eg, contraception prescribed, sexually transmitted infection tests ordered). A process evaluation will assess acceptability, adoption, fidelity and sustainability of the rebate; an economic evaluation will assess its cost-effectiveness. Analyses will be intention-to-treat | ||
| 520 | |a ETHICS AND DISSEMINATION: Ethics approval has been obtained from University of Melbourne Human and Research Ethics Committee (2022-23435-29990-3). Findings will be published in peer-reviewed journals | ||
| 520 | |a TRIAL REGISTRATION NUMBER: ACTRN12622000114741 | ||
| 650 | 4 | |a Clinical Trial Protocol | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Adolescent | |
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Primary Health Care | |
| 650 | 4 | |a Primary Prevention | |
| 700 | 1 | |a Watson, Cathy |e verfasserin |4 aut | |
| 700 | 1 | |a Chondros, Patty |e verfasserin |4 aut | |
| 700 | 1 | |a Sawyer, Susan M |e verfasserin |4 aut | |
| 700 | 1 | |a Ride, Jemimah |e verfasserin |4 aut | |
| 700 | 1 | |a Temple-Smith, Meredith |e verfasserin |4 aut | |
| 700 | 1 | |a Boyle, Douglas |e verfasserin |4 aut | |
| 700 | 1 | |a Skinner, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Patton, George C |e verfasserin |4 aut | |
| 700 | 1 | |a Lim, Megan S C |e verfasserin |4 aut | |
| 700 | 1 | |a Pirkis, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Newton, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Wardley, Amelia |e verfasserin |4 aut | |
| 700 | 1 | |a Blashki, Grant |e verfasserin |4 aut | |
| 700 | 1 | |a Guy, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Dalziel, Kim |e verfasserin |4 aut | |
| 700 | 1 | |a Sanci, Lena |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ open |d 2012 |g 13(2023), 8 vom: 16. Aug., Seite e074154 |w (DE-627)NLM215724372 |x 2044-6055 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:8 |g day:16 |g month:08 |g pages:e074154 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjopen-2023-074154 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 8 |b 16 |c 08 |h e074154 | ||